AbbVie vs NVIDIA: Founders, CEOs and History
AbbVie was founded in 2013 by Abbott Laboratories (spin-off origin) and is led by Robert A. Michael. NVIDIA was founded in 1993 by Jensen Huang, Chris Malachowsky, Curtis Priem and is led by Jensen Huang.
Company facts
Founders
AbbVie
Abbott Laboratories (spin-off origin)
Abbott Laboratories was AbbVie's corporate predecessor. AbbVie's official launch materials describe the company as formed in 2013 following separation from Abbott. Richard A.
NVIDIA
Jensen Huang
Nvidia possesses a gritty, prescient founding story, rooted entirely in a specific, technical conversation at a well-known American diner, and driven by a CEO who possessed an unshakable conviction in an unproven computational theory.
Chris Malachowsky
Chris Malachowsky co-founded NVIDIA in 1993 and became a central figure in the company's technical foundation.
Curtis Priem
Curtis Priem co-founded NVIDIA in 1993 and served as one of the company's original architects.
CEOs and their tenures
AbbVie
- Richard A. Gonzalez2013–2024
Founding Chairman and Chief Executive Officer
Served as AbbVie's chief executive officer from its formation in 2013 through June 2024 and as executive chairman through June 2025.
Source - Robert A. Michael2024–present
Chairman and Chief Executive Officer
Became chief executive officer on July 1, 2024 and chairman on July 1, 2025. He previously led finance, commercial operations, and corporate strategy roles at AbbVie.
Source
NVIDIA
- Jensen Huang1993–present
CEO
Huang has been CEO for more than 33 years, which makes him one of the longest-serving founder-CEOs in the industry. Under him NVIDIA bet early on CUDA and deep learning, bought Mellanox for networking, and moved to a yearly architecture cadence.
Source - Chris Malachowsky1993–2024
Co-Founder
Chris Malachowsky co-founded Nvidia in 1993. As Senior Vice President of Engineering and Operations, he played a critical role in developing the early graphics processing architecture and establishing Nvidia's robust engineering supply chain.
Source - Colette Kress2013–present
Executive Vice President and Chief Financial Officer
She has been CFO through NVIDIA's growth from about $4B of annual revenue to $215.9B in FY2026, and she leads its quarterly earnings communication with investors.
Source
Timeline: AbbVie and NVIDIA side by side
1993NVIDIA
Founding in Santa Clara
Jensen Huang, Chris Malachowsky, and Curtis Priem founded NVIDIA on April 5, 1993, with a focus on 3D graphics for gaming and multimedia. The founding set the company on a parallel-processing path long before AI infrastructure became the main market.
1999NVIDIA
GPU Category Defined
NVIDIA introduced the graphics processing unit concept in 1999. The milestone mattered because it framed graphics hardware as a specialized processor, a technical idea that later carried into accelerated computing and AI workloads.
2006NVIDIA
CUDA Opens GPUs to General Computing
CUDA opened GPU parallel processing to scientists, researchers, and developers outside graphics. It became the software foundation that made NVIDIA hardware useful for machine learning, simulation, and other compute-heavy workloads.
2012NVIDIA
AlexNet Shows GPU Value for Deep Learning
The AlexNet breakthrough used NVIDIA GPUs to win the ImageNet competition. The event helped convince researchers and engineers that GPUs could accelerate neural-network training at a scale CPUs could not match.
2013AbbVie
AbbVie Launches as an Independent Company
AbbVie launched after Abbott Laboratories separated its research-based pharmaceutical business and began NYSE trading under ABBV.
2015AbbVie
Pharmacyclics Acquisition Completed
AbbVie completed its acquisition of Pharmacyclics, adding Imbruvica and expanding its hematologic oncology business.
2016NVIDIA
DGX-1 AI Supercomputer
Nvidia introduced the DGX-1 deep-learning supercomputer in 2016, its first system built specifically for artificial intelligence.
2018NVIDIA
RTX Brings Real-Time Ray Tracing to Graphics
NVIDIA RTX brought real-time ray tracing into the company's graphics roadmap. The product line kept gaming and professional visualization tied to AI-enhanced rendering while Data Center was becoming more important.
2019AbbVie
Skyrizi Receives Initial U.S. Approval
The FDA approved Skyrizi for adults with moderate to severe plaque psoriasis in April 2019.
2019AbbVie
Rinvoq Receives Initial U.S. Approval
The FDA approved Rinvoq for adults with moderate to severe rheumatoid arthritis in August 2019.
2020AbbVie
Allergan Acquisition Completed
AbbVie completed the Allergan acquisition, adding neuroscience, eye care, and Allergan Aesthetics products including Botox and Juvederm.
2020NVIDIA
Mellanox Acquisition Adds Networking
NVIDIA completed the Mellanox acquisition for about $7 billion. The deal mattered because large AI and high-performance-computing clusters depend on fast networking between accelerators, not only on individual GPU speed.
2022NVIDIA
Arm Acquisition Terminated
NVIDIA and SoftBank terminated the proposed Arm acquisition because of significant regulatory challenges. The failed deal showed how closely governments watch control points in semiconductor architecture.
2022NVIDIA
Hopper H100 Announced
Nvidia announced the Hopper-architecture H100 data-center GPU in March 2022.
2023AbbVie
U.S. Humira Biosimilar Competition Begins
Humira began facing U.S. biosimilar competition, and AbbVie reported a subsequent decline in Humira revenue.
2023NVIDIA
Grace CPU Enters Data Center Roadmap
NVIDIA introduced its first data-center CPU, Grace, for large-scale AI and high-performance computing. The milestone expanded the platform from GPUs and networking into CPU-GPU system design.
2024AbbVie
ImmunoGen Acquisition Completed
AbbVie completed its acquisition of ImmunoGen, adding Elahere and antibody-drug conjugate programs.
2024AbbVie
Robert A. Michael Becomes CEO
Robert A. Michael succeeded Richard A. Gonzalez as chief executive officer effective July 1, 2024.
2024AbbVie
Cerevel Therapeutics Acquisition Completed
AbbVie completed its acquisition of Cerevel Therapeutics, adding clinical-stage neuroscience programs.
2024NVIDIA
Blackwell Architecture Launched
NVIDIA launched Blackwell as a data-center-scale architecture combining GPUs, CPUs, DPUs, interconnects, switch chips, systems, and networking adapters. The architecture became central to FY2026 Data Center demand.
2025AbbVie
Robert A. Michael Becomes Chairman
Robert A. Michael added the chairman role effective July 1, 2025, when Richard A. Gonzalez retired from the board.
2025AbbVie
FY2025 Revenue Reaches $61.160 Billion
AbbVie reported FY2025 net revenue of $61.160 billion and net income of $4.226 billion.
2026AbbVie
Q1 2026 Revenue Reaches $15.002 Billion
AbbVie reported first-quarter 2026 net revenue of $15.002 billion, up 12.4 percent on a reported basis.
2026NVIDIA
$215.9B FY2026 Revenue
NVIDIA reported $215.9 billion of FY2026 revenue, $193.7 billion of Data Center revenue, and $120.1 billion of net income. The result showed how far AI infrastructure had moved the company beyond its original PC graphics market.
Acquisitions
AbbVie
- ImmunoGen, Inc.2024$10.1B
- Cerevel Therapeutics2024$8.7B
- Allergan plc2020$63B
- Pharmacyclics, Inc.2015$21B
NVIDIA
- Groq (technology license and team)2025Undisclosed
- Run:ai2024$700M
- Excelero2022Undisclosed
- Mellanox Technologies2020$6.9B
- Cumulus Networks2020Undisclosed
- Icera2011$367M
Questions about AbbVie vs NVIDIA
Who is the CEO of AbbVie Inc. and NVIDIA Corporation?
AbbVie Inc. is led by Robert A. Michael and NVIDIA Corporation is led by Jensen Huang. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was AbbVie Inc. founded vs NVIDIA Corporation?
NVIDIA Corporation was founded in 1993 — 20 years before AbbVie Inc., which was founded in 2013. NVIDIA Corporation's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger AbbVie Inc..
How many employees does AbbVie Inc. have compared to NVIDIA Corporation?
AbbVie Inc. employs approximately 57,000 people, while NVIDIA Corporation employs approximately 42,000. AbbVie Inc. has the larger workforce at 57,000 employees, compared to NVIDIA Corporation's 42,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are AbbVie Inc. and NVIDIA Corporation headquartered?
Both AbbVie Inc. and NVIDIA Corporation are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded AbbVie Inc. and NVIDIA Corporation?
AbbVie Inc. was founded by Abbott Laboratories (spin-off origin). NVIDIA Corporation was founded by Jensen Huang, Chris Malachowsky, Curtis Priem.
Which company has a longer operating history — AbbVie Inc. or NVIDIA Corporation?
NVIDIA Corporation has been operating for approximately 33 years, making it the more established of the two companies. AbbVie Inc. has been in operation for around 13 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the AbbVie vs NVIDIA overview